Home
Scholarly Works
THE NEW DIABETES DRUG CANAGLIFLOZIN ENHANCES THE...
Conference

THE NEW DIABETES DRUG CANAGLIFLOZIN ENHANCES THE RESPONSE OF PROSTATE CANCER TO RADIOTHERAPY

Authors

Mekhaeil B; Zacharidis P; Tsakiridis E; Biziotis O-D; Broadfield L; Menjolian G; Mathurin T; Farrell T; Muti P; Liu S

Volume

139

Pagination

pp. S71-S72

Publisher

ELSEVIER IRELAND LTD

Publication Date

October 1, 2019

Name of conference

Annual Scientific Meeting of the Canadian-Association-for-Radiation-Oncology (CARO)

Conference place

Halifax, CANADA

Conference start date

October 2, 2019

Conference end date

October 5, 2019

Conference proceedings

RADIOTHERAPY AND ONCOLOGY

ISSN

0167-8140

Contact the Experts team